Cargando…

CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence

Each CYP2A6 gene variant metabolizes nicotine differently depending on its enzymatic activities. The normal nicotine metabolizer CYP2A6(*)1A is associated with high scores of nicotine dependence (5–10) on the Fagerström Test for Nicotine Dependence (FTND) scale because it encodes for enzymes that ca...

Descripción completa

Detalles Bibliográficos
Autor principal:	Akrodou, Yawo Mawuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427762/ https://www.ncbi.nlm.nih.gov/pubmed/26060595 http://dx.doi.org/10.1155/2015/491514

Ejemplares similares

Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction
por: López-Flores, Luis A., et al.
Publicado: (2017)

The Role of CYP2A6 Genetic Polymorphism in Nicotine Dependence and Tobacco Consumption among Bataknese Male Smokers
por: Soeroso, Noni Novisari, et al.
Publicado: (2018)

CYP2D6 polymorphisms and their influence on risperidone treatment
por: Puangpetch, Apichaya, et al.
Publicado: (2016)

Treatment of nicotine dependence needs be strengthened in primary health care
por: Ekblad, Mikael O.
Publicado: (2023)

Frequencies of CYP2D6 genetic polymorphisms in Arab populations
por: Alali, Mousa, et al.
Publicado: (2022)

Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation
por: Muderrisoglu, Ahmet, et al.
Publicado: (2020)

Distribution of CYP2D6 polymorphism in the Middle Eastern region
por: Khalaj, Zahra, et al.
Publicado: (2019)

Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes
por: Bloom, Adam Joseph, et al.
Publicado: (2019)

Genetic Polymorphism of CYP2A6 and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia
por: Soeroso, Noni Novisari, et al.
Publicado: (2018)

Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine
por: Goyal, Navneet, et al.
Publicado: (2021)

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
por: Silvado, Carlos Eduardo, et al.
Publicado: (2018)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line
por: Lee, Hye Ja, et al.
Publicado: (2011)

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study
por: Wickramage, Ishani, et al.
Publicado: (2017)

Effect of Nicotine on CYP2B1 Expression in a Glioma Animal Model and Analysis of CYP2B6 Expression in Pediatric Gliomas
por: Nava-Salazar, Sonia, et al.
Publicado: (2018)

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
por: Ferraldeschi, Roberta, et al.
Publicado: (2010)

Dose Optimization of Efavirenz Based on Individual CYP2B6 Polymorphisms in Chinese Patients Positive for HIV
por: Hui, KH, et al.
Publicado: (2016)

Transcription Factors AhR/ARNT Regulate the Expression of CYP6CY3 and CYP6CY4 Switch Conferring Nicotine Adaptation
por: Pan, Yiou, et al.
Publicado: (2019)

Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
por: Zhang, Y, et al.
Publicado: (2010)

Methods for smoking cessation and treatment of nicotine dependence
por: Silveira Balbani, Aracy Pereira, et al.
Publicado: (2015)

Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
por: Altieri, Barbara, et al.
Publicado: (2020)

Genetic polymorphisms analysis of CYP2D6 in the Uygur population
por: He, Xue, et al.
Publicado: (2016)

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
por: Metzger, Ingrid F., et al.
Publicado: (2019)

Association of CYP3A5(*)3, CYP3A4(*)18 & CYP2B6(*)6 polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients
por: Asadov, Chingiz, et al.
Publicado: (2023)

The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression
por: Maciaszek, Julian, et al.
Publicado: (2023)

Nicotine metabolism and its association with CYP2A6 genotype among Indigenous people in Alaska who smoke
por: Schaefer, Krista R., et al.
Publicado: (2021)

Roles of CYP2C19 Gene Polymorphisms in Susceptibility to POAG and Individual Differences in Drug Treatment Response
por: Liu, Xiang-Long, et al.
Publicado: (2016)

Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.
por: Hirvonen, A, et al.
Publicado: (1993)

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
por: Ota, Tomoko, et al.
Publicado: (2015)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Novel +90G>A Intronic Polymorphism of CYP2D6
por: Modaresi-nejad, Monir, et al.
Publicado: (2015)

Pharmacological Intervention of Nicotine Dependence
por: Jain, Raka, et al.
Publicado: (2013)

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2016)

No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
por: Vangsted, Annette J, et al.
Publicado: (2010)

Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population
por: Ahmed, Shabbir, et al.
Publicado: (2018)

A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans
por: Ryu, S, et al.
Publicado: (2017)

Brain Magnetic Resonance Imaging Features of Nicotine-Dependent Individuals and Its Correlation with Polymorphisms of Dopamine D Receptor Gene
por: Liu, Hongfeng, et al.
Publicado: (2022)

Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
por: del Casale, Antonio, et al.
Publicado: (2022)

Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients
por: Chan, Sze Wa, et al.
Publicado: (2021)

Menthol cigarette smoking and nicotine dependence
por: Hoffman, Allison C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ca6eoe7g9tou3qgmnv975shr7a